LAVA Therapeutics(LVTX) - 2023 Q4 - Annual Report

TABLE OF CONTENTS SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS Page | PART I | | | | | --- | --- | --- | --- | | Item 1. | | Identity of Directors, Senior Management and Advisors | 4 | | Item 2. | | Offer Statistics and Expected Timetable | 4 | | Item 3. | | Key Information | 4 | | Item 4. | | Information on the Company | 58 | | | Item 4A. | Unresolved Staff Comments | 86 | | Item 5. | | Operating and Financial Review and Prospects | 86 | | Item 6. | | Directors, Senior Management and Employees | 95 | ...